ABIVAX Société Anonyme (ABVX) News
Track canonical SquawkNews coverage tagged to ABVX, ABIVAX Société Anonyme. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 19 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
ABVX - Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
ABVX - Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
REGULATION | Jul 30, 2026, 08:05 PM UTC
L
Abivax shares are trading higher after Truist Securities maintained its Buy rating on the stock and raised its price target from $135 to $15
Abivax shares are trading higher after Truist Securities maintained its Buy rating on the stock and raised its price target from $135 to $155.
EQUITY | Jul 02, 2026, 06:12 PM UTC
L
Truist Securities Maintains Buy on Abivax, Raises Price Target to $155
Truist Securities analyst Gregory Renza maintains Abivax (NASDAQ: ABVX ) with a Buy and raises the price target from $135 to $155.
EQUITY | Jul 02, 2026, 11:42 AM UTC
H
Why SurgePays Shares Are Trading Higher By 59%; Here Are 20 Stocks Moving Premarket
Shares of Surgepays Inc (NASDAQ: SURG ) rose sharply in pre-market trading after the Tennessee-based wireless and fintech company amended its agreement with a Tier 1 wholesale wireless network provider. The deal restruct
RATES | Jul 02, 2026, 09:32 AM UTC
L
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at on our options activity scanner. Traders often look for
EQUITY | Jul 01, 2026, 05:35 PM UTC
L
Citizens Reiterates Market Outperform on Abivax, Maintains $187 Price Target
Citizens analyst Jason N. Butler reiterates Abivax (NASDAQ: ABVX ) with a Market Outperform and maintains $187 price target.
EQUITY | Jul 01, 2026, 01:41 PM UTC
L
Abivax shares are trading higher. The company priced its underwritten public offering of 6.40 million ADSs at $125.00 each.
Abivax shares are trading higher. The company priced its underwritten public offering of 6.40 million ADSs at $125.00 each.
EQUITY | Jul 01, 2026, 01:03 PM UTC
L
Abivax Announces Pricing Of Underwritten Public Offering Of 6.40M ADSs At $125.00 Each
Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares Upsized offering increased from the previously announced $600M to $800M at $125.00 per ADS, priced at a 2
EQUITY | Jul 01, 2026, 12:40 PM UTC
L
Jefferies Upgrades Abivax to Buy, Raises Price Target to $158
Jefferies analyst Faisal Khurshid upgrades Abivax (NASDAQ: ABVX ) from Hold to Buy and raises the price target from $108 to $158.
EQUITY | Jun 30, 2026, 08:16 PM UTC
L
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Creative Medical Tech (NASDAQ: CELZ ) stock moved upwards by 242.5% to $2.77 during Tuesday's regular session. The market value of their outstanding shares is at $2.9 million. Cuprina Holdings (Cayman) (NASDAQ: C
EQUITY | Jun 30, 2026, 05:05 PM UTC
L
Nasdaq Gains Over 300 Points; Chicago PMI Falls In June
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 300 points on Tuesday. The Dow traded up 0.28% to 52,327.93 while the NASDAQ rose 1.31% to 26,157.23. The S&P 500 also rose, gainin
MACRO | Jun 30, 2026, 04:08 PM UTC
L
Leerink Partners Maintains Outperform on Abivax, Raises Price Target to $148
Leerink Partners analyst Thomas Smith maintains Abivax (NASDAQ: ABVX ) with a Outperform and raises the price target from $140 to $148.
EQUITY | Jun 30, 2026, 03:29 PM UTC
L
AEVEX, Abivax, Watts Water Technologies And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones index gaining around 100 points on Tuesday. Shares of AEVEX Corp (NYSE: AVEX ) rose sharply after the company secured a $50 million U.S. Air Force contract to expand unmanned m
EQUITY | Jun 30, 2026, 02:01 PM UTC
L
Why Is Abivax Stock Skyrocketing Tuesday?
Abivax SA (NASDAQ: ABVX ) on Monday shared additional Phase 3 maintenance data for investigational ulcerative colitis therapy obefazimod. Following the announcement, the stock jumped nearly 36%. Abivax Reports Strong Pha
REGULATION | Jun 30, 2026, 01:03 PM UTC
L
Wedbush Maintains Neutral on Abivax, Raises Price Target to $110
Wedbush analyst David Nierengarten maintains Abivax (NASDAQ: ABVX ) with a Neutral and raises the price target from $90 to $110.
EQUITY | Jun 30, 2026, 12:53 PM UTC
L
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Abivax (NASDAQ: ABVX ) shares increased by 36.0% to $130.74 during Tuesday's pre-market session. The company's market cap stands at $7.6 billion. Cuprina Holdings (Cayman) (NASDAQ: CUPR ) shares moved upwards by
EQUITY | Jun 30, 2026, 12:05 PM UTC
H
Why AeroVironment Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket
Shares of AeroVironment, Inc. (NASDAQ: AVAV ) rose sharply in pre-market trading after the company reported better-than-expected financial results for the fourth quarter of fiscal 2026. AeroVironment guided for fiscal 20
EARNINGS | Jun 30, 2026, 10:10 AM UTC
M
ABVX: Grizzly Denies Short Report
ABVX volatility pops as Grizzly Research denies working on a short report on the name
EQUITY | Jun 24, 2026, 04:11 PM UTC
L
ABVX Sees Vol
ABVX is experiencing some volatility
EQUITY | Jun 24, 2026, 03:19 PM UTC